Bill introduced to lower drug costs for veterans
Two Democratic lawmakers who are both Army veterans have introduced legislation that would allow service members, veterans, and their families to access the lowest government-negotiated prescription drug prices available through any federal health program. Representatives Eugene Vindman of Virginia and Pat Ryan of New York, both members of the House Armed Services Committee, are sponsoring the MISSION RX Act, which would extend Medicare's negotiated drug pricing to everyone covered by Tricare or the Department of Veterans Affairs health system. Under the proposal, beneficiaries would automatically pay whichever price is lower: the rate negotiated by the Centers for Medicare & Medicaid Services or the cost already offered through their existing Tricare or VA coverage.
Currently, only Medicare enrollees benefit from the drug pricing framework established under the Inflation Reduction Act of 2022. That law authorized CMS to negotiate prices on certain high-cost prescription medications, a change that does not automatically extend to other federal health programs despite the fact that Tricare and VA healthcare are also government-run systems. The result is that veterans and active-duty families can end up paying more for the same medications than Medicare recipients, even though all three programs are funded by taxpayers and serve populations with significant healthcare needs.
The legislation would affect millions of people enrolled in VA healthcare and Tricare, the health insurance program that covers active-duty service members, retirees, and their dependents. For disabled veterans specifically, many of whom rely on VA healthcare for service-connected conditions and often take multiple prescription medications long-term, access to the lowest available government price could mean substantial savings on out-of-pocket costs. Veterans who use both VA care and Tricare, as well as those who supplement VA prescriptions with medications obtained elsewhere, would see the most direct impact.
Representative Vindman, who served 25 years in the Army as a paratrooper, infantry officer, and JAG Corps attorney, said in a statement that service members and veterans should not have to worry about affording needed prescription drugs after their sacrifices. Representative Ryan, an intelligence officer who deployed to Iraq and earned two Bronze Star Medals, called it "absolutely unacceptable" that military families are forced to pay more than other Americans for identical medications. The bill currently has four Democratic co-sponsors and backing from major veterans organizations including the Veterans of Foreign Wars, Marine Corps League, Fleet Reserve Association, Air Force Sergeants Association, and Commissioned Officers Association Public Health Service.
If passed, the legislation would expand taxpayer savings beyond the $6 billion annually that CMS already estimates from the original Medicare drug pricing measures. For disabled veterans managing chronic conditions related to their service, prescription costs represent a significant and ongoing financial burden that compounds other challenges like reduced earning capacity and increased medical needs. This bill recognizes that veterans who earned their healthcare benefits through military service deserve the same pricing protections extended to civilian Medicare recipients, particularly when both programs negotiate on behalf of the federal government.
The bill faces an uncertain path in the Republican-controlled House, where it has not yet attracted bipartisan support. Veterans who want to see this legislation advance should consider contacting their representatives to express support, particularly if they have experienced high prescription costs through VA or Tricare. Staying informed about the bill's progress and discussing prescription cost concerns with veterans service organizations can help build momentum for changes that would make medications more affordable for those who served.